Company Name
GRAIL, LLC
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
ISIN:
US3847471014
CIK:
0001699031
CUSIP:
384747101
Currency:
USD
Full Time Employees:
1,000
Phone:
833 694 2553
Website:
https://grail.com
Fiscal Year End:
December
IPO Date:
Jun 25, 2024
Description:
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Address:
1525 O?Brien Drive, Menlo Park, CA, United States, 94025